Overview
Dr. Pavlisko holds an undergraduate degree in Biochemistry from Clemson University and received her Doctor of Medicine from the Medical University of South Carolina. She completed her residency and is board certified in both Anatomic and Clinical Pathology. She trained as a pulmonary/thoracic pathology fellow at Duke University Medical Center under the mentorship of Drs. Victor Roggli and Thomas Sporn, two of the world’s leading Pulmonary Pathologist with expertise in pneumoconiosis and mesothelioma. She joined the faculty at Duke in 2011 as an Assistant Professor of Pathology, and her work is focused in thoracic, cardiovascular and transplant pathology as well as postmortem examination. Since starting her independent position, Dr. Pavlisko has developed expertise in neoplastic and non-neoplastic diseases of the lung and mediastinum with a special interest in lung transplantation and diseases of the pleura for which she is widely recognized as an authority. She currently serves as Chief of the Pulmonary/Thoracic Pathology Section.
Dr. Pavlisko’s clinical activities encompass pulmonary/thoracic and cardiovascular pathology, including transplantation, biomarker testing and autopsy pathology. Her primary research focus has centered on malignant mesothelioma and chronic lung allograft dysfunction (CLAD). She has published over 65 manuscripts and has 6 book chapters, the latter all centered on occupational diseases of the lungs and pleura. Since 2017, Dr. Pavlisko has co-chaired the lung steering committee for the Banff Foundation for Allograft Pathology. She is also an active member of the International Society for Heart and Lung Transplantation. Dr. Pavlisko has collaborations with the Departments of Pulmonary, Allergy and Critical Care Medicine and Cardiothoracic Surgery.
In addition to her clinical and research activities, Dr. Pavlisko is active in Duke University Hospital’s Clinical Laboratories and currently serves as the Medical Director of the Division of Anatomic Pathology and Digital Analytics (DAPDA) Laboratory, which includes Histology, Immunohistochemistry, FISH, and Image Analysis.
Current Duke Appointments & Affiliations
Recent Scholarly Works
Lyme Carditis in a Transplanted Heart: A Rare Cause of Early Conduction Abnormalities.
Journal article JACC Case Rep · June 17, 2026 BACKGROUND: Lyme disease, caused by Borrelia burgdorferi, is the most common vector-borne infection in North America. Cardiac involvement occurs in approximately 1% to 10% of untreated infections and most commonly manifests as atrioventricular conduction a ... Full text Link to item CiteInternational Society for Heart and Lung Transplantation Scientific Statement on pulmonary antibody-mediated rejection and proposed graft, antibody, and pathology (GAP) definition.
Journal article J Heart Lung Transplant · June 11, 2026 Antibody-mediated rejection (AMR) is an increasingly recognized form of rejection and cause of graft failure after lung transplantation. AMR has been the focus of extensive research over the past decade. Despite growing awareness and recent advances in our ... Full text Link to item CiteDevelopment of Mesothelioma in Organ Transplant Recipients: A Comprehensive Study of 10 Cases.
Journal article Arch Pathol Lab Med · May 11, 2026 CONTEXT.—: The development of malignancy after organ transplant has been well recognized as a complication of long-term posttransplant immunosuppression. Although rare cases of mesothelioma have been reported in transplant recipients, a comprehensive revie ... Full text Link to item CiteRecent Grants
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD
ResearchCo Investigator · Awarded by National Institutes of Health · 2015 - 2031Lung Transplant Clinical Trial Network (LT-CTN)
ResearchCo Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2021 - 2028CXCR2 expression in lung neuroendocrine neoplasms
ResearchMentor · Awarded by Lung Cancer Initiative of North Carolina · 2024 - 2025View All Grants